Polyphron Raises $20M to Build Physical Verification Layer for AI-Driven Biology

<p>NEW YORK, Sept. 18, 2026 &#8212; Polyphron, a company building artificial human biology to transform drug development and treat disease, has announced $20 million in seed financing led by Quiet Capital, with participation from Gradient, Haystack, and Compound. Polyphron trains frontier AI models to manufacture and simulate living tissue to create the verification substrate for AI-driven [&#8230;]</p> <p>The post <a href="https://www.hpcwire.com/off-the-wire/polyphron-raises-20m-to-build-physical-verification-layer-for-ai-driven-biology/">Polyphron Raises $20M to Build Physical Verification Layer for AI-Driven Biology</a> appeared first on <a href="https://www.hpcwire.com">HPCwire</a>.</p>